Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02382172 · ClinicalTrials.gov registry record · NA

Social Cognition and Interaction Training for Autism

A NA study of Autism and Social Behavior, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
44
Enrollment target
1
Study location

NCT02382172: Completed NA study of Autism and Social Behavior, sponsored by University of North Carolina, Chapel Hill.

NCT02382172 is a NA study of Autism and Social Behavior that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 44 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02382172, a NA study of Autism and Social Behavior, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

Purpose: To collect outcome measures such as eye tracking and questionnaire data prior to and following a group based clinical therapy program to determine the effectiveness of the therapy approach. The therapy program is aimed at improving social cognitions and skills of individuals who find social situations difficult, stressful and/or uncomfortable and with a desire to enhance skills required for social interactions. Participants: Cohorts of individuals aged 10-69 years old with symptoms of a neurodevelopment disorder, who have general difficulty with social interactions. Procedures: Participants enrolled in a clinical therapy program for improvement of social cognitions and skills will complete eye tracking tasks, several questionnaires and rating scales, and a diagnostic interview prior to and following the 8 week therapy program. The post treatment assessments will be conducted within a week of the therapy completion and then again approximately 2 months after the last therapy session. The entire study duration is expected to be approximately 17 weeks. These outcome measures will measure the effectiveness of the treatment.

Primary Outcome

Participants will complete an eyetracking task both before and after the Social Skills training clinic. The eyetracking task will be presented on a Tobii 1750 eyetracker integrated with a 17" display monitor (Tobii Technology, Stockholm, Sweden). The task will be an interactive visual exploration task that is a validated measure of social attention. It's a 15-minute eye tracking task, which is non-invasive and completely safe. During the task, participants will be asked to look at two children p

Conditions Studied

Interventions

  • OTHER Treatment as Usual (TAU)
  • BEHAVIORAL Social Cognition and Interaction Training for Autism (SCIT-A)

Study Locations (1)

North Carolina

  • Carolina Institute for Developmental Disabilities - Carrboro

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2015-01
Est. Completion 2017-01
Phase NA

What the finished NCT02382172 record still lists

NCT02382172 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 183-participant average among 104 other Autism trials with a reported enrollment target (76% lower).

The record links to 2 conditions, with Autism appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual (TAU) is the first listed.

NCT02382172 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT02382172 about?

NCT02382172 is a clinical study titled "Social Cognition and Interaction Training for Autism". Purpose: To collect outcome measures such as eye tracking and questionnaire data prior to and following a group based clinical therapy program to determine the effectiveness of the therapy approach. The therapy program is aimed at improving social cognitions and skills of individuals who find social...

What is the current status of trial NCT02382172?

This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2015-01. Estimated completion is 2017-01.

What conditions does trial NCT02382172 study?

This clinical trial studies the following conditions: Autism, Social Behavior.

What interventions are being tested in trial NCT02382172?

The interventions under investigation include: Treatment as Usual (TAU) (OTHER), Social Cognition and Interaction Training for Autism (SCIT-A) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02382172?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02382172 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02382172's enrollment target sits among peer trials

44 60th of 104 higher than 41 of 104 other Autism trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323945 · 44 participants · NA

    Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury

  • NCT03093909 · 44 participants · Phase 1

    Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

  • NCT03104491 · 44 participants · Phase 1

    Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

  • NCT03781765 · 44 participants · Phase 4

    Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02382172, the US trial registry maintained by the National Library of Medicine. NCT02382172 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.